View in EDS PDF Full Text

Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.
Authors: Berger MD; Department of Medical Oncology, University Hospital and University of Berne, Berne, Switzerland., Heini AD; Department of Medical Oncology, University Hospital and University of Berne, Berne, Switzerland., Seipel K; Department of Clinical Research, University Hospital and University of Berne, Berne, Switzerland., Mueller B; Department of Clinical Research, University Hospital and University of Berne, Berne, Switzerland., Angelillo-Scherrer A; Department of Hematology, University Hospital and University of Berne, Berne, Switzerland., Pabst T; Department of Medical Oncology, University Hospital and University of Berne, Berne, Switzerland.
Source: Hematological oncology [Hematol Oncol] 2017 Dec; Vol. 35 (4), pp. 789-796. Date of Electronic Publication: 2016 Jun 15.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 27301773
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Berger+MD%22">Berger MD</searchLink>; Department of Medical Oncology, University Hospital and University of Berne, Berne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Heini+AD%22">Heini AD</searchLink>; Department of Medical Oncology, University Hospital and University of Berne, Berne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Seipel+K%22">Seipel K</searchLink>; Department of Clinical Research, University Hospital and University of Berne, Berne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mueller+B%22">Mueller B</searchLink>; Department of Clinical Research, University Hospital and University of Berne, Berne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Angelillo-Scherrer+A%22">Angelillo-Scherrer A</searchLink>; Department of Hematology, University Hospital and University of Berne, Berne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pabst+T%22">Pabst T</searchLink>; Department of Medical Oncology, University Hospital and University of Berne, Berne, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228307268%22">Hematological oncology</searchLink> [Hematol Oncol] 2017 Dec; Vol. 35 (4), pp. 789-796. <i>Date of Electronic Publication: </i>2016 Jun 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8307268 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1099-1069 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202780232%22">02780232 </searchLink><i>NLM ISO Abbreviation: </i>Hematol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27301773
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hon.2307
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 789
    Titles:
      – TitleFull: Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Berger MD
      – PersonEntity:
          Name:
            NameFull: Heini AD
      – PersonEntity:
          Name:
            NameFull: Seipel K
      – PersonEntity:
          Name:
            NameFull: Mueller B
      – PersonEntity:
          Name:
            NameFull: Angelillo-Scherrer A
      – PersonEntity:
          Name:
            NameFull: Pabst T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2017 Dec
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1099-1069
          Numbering:
            – Type: volume
              Value: 35
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Hematological oncology
              Type: main
ResultId 1